Literature DB >> 22510289

Drug resistance in Vibrio cholerae strains isolated from clinical specimens.

Farideh Rahmani1, Abbas Ali Imani Fooladi, Seyed Mahmood Amin Marashi, Mohammad Reza Nourani.   

Abstract

Cholera is a serious epidemic and endemic disease caused by the Gram-negative bacterium Vibrio cholerae. SXT is an integrative conjugation element (ICE) that was isolated from a V. cholerae; it encodes resistance to the antibiotics chloramphenicol, streptomycin and sulfamethoxazole/trimethoprim. One hundred seven V. cholerae O1 strains were collected from cholera patients in Iran from 2005 to 2007 in order to study the presence of SXT constin and antibiotic resistance.The study examined 107 Vibrio cholerae strains isolated from cholera prevalent in some Iranian provinces. Bacterial isolation and identification were carried out according to standard bacteriological methods. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) to four antibiotics (chloramphenicol, streptomycin, sulfamethoxazole, and trimethoprim) were determined by broth microdilution method. PCR was employed to evaluate the presence of established antibiotic resistance genes and SXT constin using specific primer sets.The resistance of the clinical isolates to sulfamethoxazole, trimethoprime, chloramphenicol, and streptomycin was 97%, 99%, 99%, and 90%, respectively. The data obtained by PCR assay showed that the genes sulII, dfrA1, floR, strB, and sxt element were present in 95.3%, 95.3%, 81.3%, 95.3%, and 95.3% of the V. cholerae isolates.The Vibrio strains showed the typical multidrug-resistance phenotype of an SXT constin. They were resistant to sulfamethoxazole, trimethoprime, chloramphenicol, and streptomycin. The detected antibiotic resistance genes included dfrA for trimethoprim and floR, strB, sulII and int, respectively, for chloramphenicol, streptomycin, sulfamethoxazole, as well as the SXT element.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22510289     DOI: 10.1556/AMicr.59.2012.1.8

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  7 in total

1.  Clonal Dissemination of a Single Vibrio cholerae O1 Biotype El Tor Strain in Sistan-Baluchestan Province of Iran During 2013.

Authors:  Bita Bakhshi; Azam Mahmoudi-Aznaveh; Ali Salimi-Khorashad
Journal:  Curr Microbiol       Date:  2015-04-11       Impact factor: 2.188

2.  Increased survival of antibiotic-resistant Escherichia coli inside macrophages.

Authors:  Migla Miskinyte; Isabel Gordo
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

3.  Dysbiosis individualizes the fitness effect of antibiotic resistance in the mammalian gut.

Authors:  Luís Leónidas Cardoso; Paulo Durão; Massimo Amicone; Isabel Gordo
Journal:  Nat Ecol Evol       Date:  2020-07-06       Impact factor: 19.100

Review 4.  A review approaches to identify enteric bacterial pathogens.

Authors:  Jafar Amani; Seyed Ali Mirhosseini; Abbas Ali Imani Fooladi
Journal:  Jundishapur J Microbiol       Date:  2014-12-10       Impact factor: 0.747

5.  Enhanced Survival of Rifampin- and Streptomycin-Resistant Escherichia coli Inside Macrophages.

Authors:  Paulo Durão; Daniela Gülereşi; João Proença; Isabel Gordo
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

6.  Bovine Lactoferrin and Lactoferrin-Derived Peptides Inhibit the Growth of Vibrio cholerae and Other Vibrio species.

Authors:  Erika Acosta-Smith; Karina Viveros-Jiménez; Adrian Canizalez-Román; Magda Reyes-Lopez; Jan G M Bolscher; Kamran Nazmi; Hector Flores-Villaseñor; Gerardo Alapizco-Castro; Mireya de la Garza; Jesús J Martínez-Garcia; Jorge Velazquez-Roman; Nidia Leon-Sicairos
Journal:  Front Microbiol       Date:  2018-01-11       Impact factor: 5.640

7.  Florfenicol Resistance in Enterobacteriaceae and Whole-Genome Sequence Analysis of Florfenicol-Resistant Leclercia adecarboxylata Strain R25.

Authors:  Yuanyuan Ying; Fei Wu; Chongyang Wu; Yi Jiang; Min Yin; Wangxiao Zhou; Xinyi Zhu; Cong Cheng; Licheng Zhu; Kewei Li; Junwan Lu; Teng Xu; Qiyu Bao
Journal:  Int J Genomics       Date:  2019-10-01       Impact factor: 2.326

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.